Clinical Trials Logo

Filter by:
NCT ID: NCT05408429 Completed - Clinical trials for Pneumococcal Disease

Safety and Immunogenicity of 20vPnC in Toddlers With 2 Prior Doses of Prevenar 13

Start date: June 24, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to understand the safety and effects of a study vaccine (20vPnC) in toddlers who had 2 prior doses of Prevnar 13. This study is being conducted in children who: - are between 12 to 23 months of age; - are healthy as determined by the study doctors; - have received 2 doses of Prevnar 13 during the first year in life. Participants in this study will receive either 1 dose or 2 doses of the study vaccine or 1 dose of Prevnar 13 as a shot in the muscle. During the study, participants will have to come to the study clinic to receive the vaccines and have blood sample collected. The study team will work with participants' parents or legal guardians to monitor any unwanted reactions to the vaccines. Participants are expected to take part in this study for about 1 or 3 months, for 1 dose or 2 dose schedules, respectively.

NCT ID: NCT05406687 Completed - Cancer Clinical Trials

Cancer Prevention and Early Detection Among the Homeless Population: The Health Navigator Model

CANCERLESS
Start date: June 8, 2022
Phase: N/A
Study type: Interventional

Prevention and early detection are key for the decrease of cancer-related mortality. However, socially deprived population groups don't have the privilege of unburdened access to the healthcare system. The EU-funded CANCERLESS project aims to develop an evidence-based, patient-centred innovation that reinforces patients through health education and social support and fosters timely access to primary and secondary prevention services. Based on the combination of the tested Patient Navigator Model and the Patient Empowerment Model, CANCERLESS will develop the Health Navigator Model for Europe, addressed to the underserved population.

NCT ID: NCT05405829 Completed - Pneumonia Clinical Trials

Health Education to Caregivers to Reduce Aspiration Pneumonia

HECGPN
Start date: May 30, 2019
Phase: N/A
Study type: Interventional

Randomized clinical study with a control group for assessing the decrease in the incidence of pneumonia, in a 12-month follow-up, in older people with cognitive impairment, risk of bronchial aspiration, risk of malnutrition and dependence to perform basic activities of daily living, through the design and implementation of an educational program. to the caregivers of these patients.

NCT ID: NCT05404243 Completed - Pilonidal Sinus Clinical Trials

Clinical Trial to Test the Phenolization in Sacrococcygeal Pilonidal Disease

SPQF
Start date: January 1, 2021
Phase: Phase 4
Study type: Interventional

Randomized clinical trial to test the efficacy and safety of phenolization in uncomplicated Sacrococcygeal pilonidal disease

NCT ID: NCT05404152 Completed - Clinical trials for Neurocognitive Disorder, Etiology of Neurocognitive Disorder

Evaluation of Cognitive Impairment in the Elderly Admitted to Nursing Homes

Start date: December 31, 2021
Phase:
Study type: Observational

This research aims at analysing the profile of the elderly with cognitive impairment (IC) and inquiring about the mental illnesses that cause cognitive impairment of a population (elderly admitted to nursing homes with a high incidence).

NCT ID: NCT05401643 Completed - Breast Cancer Clinical Trials

Evaluation of the Impact of a Multidimensional ICT Intervention on the Quality of Life of Breast Cancer Survivors

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

mACMA is a pilot study that is developed for breast cancer survivors of the Hospital Clinic of Barcelona. The objective of this study is to evaluate the progress in quality of life through the introduction of a mobile phone App that allows for symptom tracking, physical activity tracking and a calendar of patient-oriented events organized by patient organizations. This study is a two-arm randomized clinical trial. This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 875351.

NCT ID: NCT05401188 Completed - Appendicitis Clinical Trials

Clinical Trial for a Outpatient Clinical Management of Urgent Laparoscopic Appendectomy

ASI
Start date: June 1, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the safety and efficacy of outpatient management of uncomplicated acute appendicitis. For this purpose, a randomized clinical trial was designed. Selected patients who have undergone surgery for acute appendicitis are randomized into two groups. One group with hospitalization and another group without admission.

NCT ID: NCT05399680 Completed - Clinical trials for Peripheral Arterial Disease

Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access

RADIANCY
Start date: June 29, 2022
Phase: N/A
Study type: Interventional

The primary objective of this clinical investigation is to evaluate acute safety and efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System, when used with the BRITE TIP RADIANZ™ Guiding Sheath and SABERX RADIANZ™ PTA Balloon Catheter, to deploy the S.M.A.R.T.™ Nitinol Stent, in the treatment of patients with obstructive iliac or femoropopliteal arterial disease via radial artery access.

NCT ID: NCT05399238 Completed - Clinical trials for Burning Mouth Syndrome

Thermography and Burning Mouth Syndrome

TDSBA
Start date: May 1, 2022
Phase:
Study type: Observational

Medical thermography is a noninvasive technique that allows an examiner to visualize and estimate the temperature of the body . This technique allows for an evaluation of the functionality of the structures, which is why it is considered a physiological test and records the variation in the surface temperature of the human body based on the infrared radiation emitted by the surface of that body .Subjects with burning mouth syndrome (BMS) have altered sensitivity and pain thresholds for thermal stimuli compared to a control group An objective of this study is to standardize temperature values derived from thermograms of the tongue in BMS .

NCT ID: NCT05398913 Completed - Clinical trials for Spinal Cord Injuries

Effects of Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury

RIMOFATSCI-1
Start date: May 12, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Randomized placebo-controlled safety and feasibility study with crossover design (3 arms). Placebo or Rimonabant 2.5mg or Rimonabant 5mg will be administered for 5 days. Exploratory efficacy will be tested using six-min walking test.